Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-26-059041
Filing Date
2026-05-12
Accepted
2026-05-12 08:30:05
Documents
1
X0202

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5980
  Complete submission text file 0001104659-26-059041.txt   7876
Mailing Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031
Business Address 6272 WEST 91ST AVENUE WESTMINSTER CO 80031 415 336 8917
TriSalus Life Sciences, Inc. (Subject) CIK: 0001826667 (see all company filings)

EIN.: 853009869 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91951 | Film No.: 26966004
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)

Mailing Address SADDLERS' HOUSE 5TH FLOOR, 44 GUTTER LANE, LONDON United Kingdom
Business Address SADDLERS' HOUSE 5TH FLOOR, 44 GUTTER LANE, LONDON United Kingdom 02038614361
Utmost Group Plc (Filed by) CIK: 0002046077 (see all company filings)

EIN.: 616132186 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: SCHEDULE 13G